KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Gains from Investment Securities (2023 - 2025)

Biocryst Pharmaceuticals' Gains from Investment Securities history spans 9 years, with the latest figure at $6.0 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 94.62% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $8.8 million, up 17.41%, while the annual FY2025 figure was $8.8 million, 17.41% up from the prior year.
  • Gains from Investment Securities reached $6.0 million in Q4 2025 per BCRX's latest filing, up from $1.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $6.0 million in Q4 2025 to a low of -$1.6 million in Q2 2024.
  • Average Gains from Investment Securities over 3 years is $1.9 million, with a median of $1.8 million recorded in 2025.
  • Peak YoY movement for Gains from Investment Securities: soared 164.72% in 2024, then plummeted 51.0% in 2025.
  • A 3-year view of Gains from Investment Securities shows it stood at $1.2 million in 2023, then skyrocketed by 164.72% to $3.1 million in 2024, then soared by 94.62% to $6.0 million in 2025.
  • Per Business Quant, the three most recent readings for BCRX's Gains from Investment Securities are $6.0 million (Q4 2025), $1.8 million (Q3 2025), and -$299000.0 (Q2 2025).